PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24361399-13	2014	Finally, experiments using T47D (wild-type p53) and MDA-MB-435 (mutant p53) cell lines suggested that tamoxifen induces p53-independent ROS production as well as p53-dependent senescence in breast cancer cells.	Tamoxifen	102-111	tumor protein p53	Homo sapiens	43-46	
24361399-13	2014	Finally, experiments using T47D (wild-type p53) and MDA-MB-435 (mutant p53) cell lines suggested that tamoxifen induces p53-independent ROS production as well as p53-dependent senescence in breast cancer cells.	Tamoxifen	102-111	tumor protein p53	Homo sapiens	71-74	
24361399-13	2014	Finally, experiments using T47D (wild-type p53) and MDA-MB-435 (mutant p53) cell lines suggested that tamoxifen induces p53-independent ROS production as well as p53-dependent senescence in breast cancer cells.	Tamoxifen	102-111	tumor protein p53	Homo sapiens	71-74	
24361399-13	2014	Finally, experiments using T47D (wild-type p53) and MDA-MB-435 (mutant p53) cell lines suggested that tamoxifen induces p53-independent ROS production as well as p53-dependent senescence in breast cancer cells.	Tamoxifen	102-111	tumor protein p53	Homo sapiens	71-74	
24361399-14	2014	SIGNIFICANCE: These results demonstrate that tamoxifen promotes senescence through a ROS-p53-p21(Cip1/WAF1) dependent pathway by inhibiting CK2 activity in breast cancer and colon cancer cells.	Tamoxifen	45-54	tumor protein p53	Homo sapiens	89-92